Oxaliplatin Injection bulk supplier for pharma manufacturers

Oxaliplatin Injection Suppliers & Bulk Manufacturers

Available Forms: Solution for Injection

Available Strengths: 50 mg/10 mL, 100 mg/20 mL, 200 mg/40 mL

Reference Brands: Eloxatin(US & EU)

Category: Oncology Cancer Care

Oxaliplatin Injection is available in Solution for Injection and strengths such as 50 mg/10 mL, 100 mg/20 mL, 200 mg/40 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Oxaliplatin Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Oxaliplatin Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Product Description: Oxaliplatin Injection is a platinum-based chemotherapeutic agent available in 50 mg, 100 mg, and 200 mg strengths for IV infusion. Widely used in the U.S. and EU, it is a key component of the FOLFOX regimen for the treatment of advanced and metastatic colorectal cancer. Oxaliplatin interferes with DNA replication, leading to cancer cell death. Approved for both adjuvant and palliative therapy, it plays a vital role in oncology B2B distribution. Available as a solution for infusion, Oxaliplatin supports effective cancer management and enhances treatment outcomes for colorectal cancer patients across global markets

Frequently Asked Questions

Yes, Oxaliplatin Injection is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Oxaliplatin Injection is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Vimseltinib

Strength: 14 mg; 20 mg; 30 mg

Form: Capsules

Reference Brands: Romvimza

View Details
Atezolizumab

Strength: 1200 mg/20 mL

Form: Intravenous infusion

Reference Brands: Tecentriq® (EU & US)

View Details
Durvalumab

Strength: 120 mg/4 mL, 500 mg/10 mL

Form: Injection

Reference Brands: Imfinzi® (US & EU)

View Details
Sunitinib

Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg

Form: Tablet

Reference Brands: Sutent® (EU & US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.